Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)
Portugal800 participantsStarted 2026-06-10
Plain-language summary
The goal of this observational study is to evaluate the clinical outcomes and management approaches of cardiogenic shock throughout the years in adult patients admitted to a Cardiology Department. The main questions it aims to answer are:
* How have management strategies and clinical outcomes for cardiogenic shock evolved over time?
* How do clinical, laboratory, and advanced hemodynamic monitoring parameters relate to patient survival and overall prognosis in this population?
Researchers will evaluate clinical data collected from 2017 onwards to see if therapeutic advancements and changes in clinical management over the years have led to improved patient survival and quality of care.
Participants will:
* Receive standard, routine medical care for cardiogenic shock as determined by their clinical team (no experimental interventions will be introduced).
* Have their clinical, laboratory, and imaging data collected from hospital electronic records during their stay.
* Be followed for up to 1 year after hospital admission to evaluate long-term survival and clinical outcomes.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
Cardiogenic shock according to the following criteria:
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since COR-SHOCK is an observational registry rather than a treatment trial, does participating in it change anything about the actual care or treatments I would receive for my cardiogenic shock, or am I simply agreeing to have my data collected?
2This registry is tracking all-cause mortality at 30 days after admission — what does that tell me about how serious my condition is right now, and how does my current situation compare to typical outcomes for patients with cardiogenic shock?
3Given that this is a data-collection registry and not a Phase 1, 2, or 3 interventional trial, is there any direct medical benefit to me personally from enrolling, or is the main purpose to improve understanding and future treatment for others with cardiogenic shock?
4Since the registry includes patients with cardiogenic shock after a heart attack as well as other causes of cardiogenic shock, does the specific cause of my cardiogenic shock affect whether my data would be particularly meaningful to contribute, or whether any other active treatment trials might be a better fit for my situation?
5What are the privacy and data-sharing implications of having my health information entered into this outcomes registry, and are there any time-sensitive decisions I need to make about enrolling given how critical my current condition is?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
All-Cause Mortality at 30 days after admission
Timeframe: From date of hospital admission to 30 days after admission